Asdaq SMB

References (2)

Title : Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer's disease - Nayak_2024_Saudi.Pharm.J_32_101888
Author(s) : Nayak A , Raju R , Das P , Das K , Suvitha A , Ranjan Meher B , Alobid S , Almoteer AI , Almadani ME , Alshehri A , Alghamdi A , Ahmad F , Rabbani SI , Asdaq SMB , Nayeem N
Ref : Saudi Pharm J , 32 :101888 , 2024
Abstract : Nayak_2024_Saudi.Pharm.J_32_101888
ESTHER : Nayak_2024_Saudi.Pharm.J_32_101888
PubMedSearch : Nayak_2024_Saudi.Pharm.J_32_101888
PubMedID: 38090736

Title : Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies - Bhanderi_2021_Materials.(Basel)_14_
Author(s) : Bhanderi M , Shah J , Gorain B , Nair AB , Jacob S , Asdaq SMB , Fattepur S , Alamri AS , Alsanie WF , Alhomrani M , Nagaraja S , Anwer MK
Ref : Materials (Basel) , 14 : , 2021
Abstract : Bhanderi_2021_Materials.(Basel)_14_
ESTHER : Bhanderi_2021_Materials.(Basel)_14_
PubMedSearch : Bhanderi_2021_Materials.(Basel)_14_
PubMedID: 34771817